ABOUT US

Who We Are

PharPoint Research provides contract research organization (CRO) services to help sponsors meet their clinical trial goals.

PharPoint Research is a US-based, privately owned contract research organization (CRO) that provides nimble drug development solutions to clients of all sizes.

Founded in 2007 by three long-time colleagues, PharPoint offers a range of clinical trial services and solutions (including clinical operations, project management, biostatistics, and clinical data management) to clients of all sizes across a wide range of therapeutic areas and clinical trial phases.

At PharPoint, we put our clients and the patients whose lives they impact at the core of everything we do.

Our Mission
Providing an alternative to rigid, unimaginative, quality-compromised clinical research organizations.

WHY CHOOSE PHARPOINT?

What makes the PharPoint team different?

CLIENT-FOCUSED APPROACH

PharPoint’s client-focused, personalized and attentive approach ensures our clients (regardless of size) are able to meet their study goals. Our team is agile and scalable to meet our clients evolving needs.

COLLABORATIVE TEAM

PharPoint provides clients with a team that is attentive, experienced, and collaborative. From the start, our teams work closely with cross-functional groups to ensure high quality deliverables are produced according to industry-best timelines.

FASTER TIMELINES

Thanks in part due to our nimble size and experienced teammates, PharPoint is able to provide clients with faster study timelines — because patients are waiting.

EXPLORE RELATED RESOURCES

No Surprises: PharPoint’s Transparent Approach to Changes in Scope

How does your CRO handle changes in scope (CIS)? Learn more about PharPoint's transparent process.

Exploring Benefits, Eligibility, and Key Considerations for Sponsors Pursuing Orphan Drug Designation

Pursuing Orphan Drug Designation? Navigating the nuances of eligibility and the application process can be complex.

Case Study: Proactive Risk Mitigation in Early Phase Oncology

This case study highlights how the PharPoint team supported a Phase 1 FIH oncology study that completed LPLV and database lock ahead of schedule.

RECENT INDUSTRY RECOGNITIONS

2023 2024 TBJ Best Place To Work PharPoint

2024, 2023 Triangle Business Journal Best Place to Work

PharPoint was proud to have been named to the Triangle Business Journal’s “Best Places to Work” List in 2023 and again in 2024! The Best Places to Work Awards are an annual program that recognize outstanding companies for positive work environments and policies that employees value. Winners are chosen based on employee survey feedback, conducted annually by The Triangle Business Journal.

logo-triangle

2020 Triangle Business Journal Life Sciences Award: “Most Innovative CRO”

PharPoint is proud to have received the “Most Innovative CRO” award by the Triangle Business Journal! Based in the Research Triangle region of North Carolina, a nexus of the CRO industry, the business journal holds its Life Sciences Awards each year to recognize individuals and research organizations that are leading the field.

Scrip Finalist Icon_2019

2019 Scrip Awards “Best Specialist CRO” Finalist

PharPoint is incredibly proud to have been selected as a finalist in the 2019 Scrip Awards “Best Specialist CRO” category alongside some of our innovative industry peers. The Scrip Awards are voted on by judges who are senior executives from biopharma and investment firms along with clinical research leaders.

Learn more about working with the PharPoint team.

For more information about how we can support your Phase I through Phase IV clinical trial needs, reach out to our team.